Alto Neuroscience ANRO Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|
| $176.98M+4.9% | $168.73M+104% | $82.55M+70.8% | ||
| $177.72M+4.9% | $169.34M+98.3% | $85.39M— | ||
| $1.87M-29.8% | $2.67M+141% | $1.11M— | ||
| $184.69M+4.0% | $177.54M+105% | $86.63M— | ||
| $6.99M-13.5% | $8.09M+561% | $1.22M— | ||
| $585K— | $0— | $0— | ||
| $11.33M+13.2% | $10.01M+78.4% | $5.61M— | ||
| $16.17M+57.7% | $10.25M+4.0% | $9.86M— | ||
| $33.55M+28.6% | $26.08M+55.0% | $16.82M— | ||
| $3K0.0% | $3K— | $0— | ||
| -$201.63M-45.7% | -$138.4M-79.8% | -$76.97M— | ||
| $151.14M-0.2% | $151.46M+311% | -$71.67M-86.6% | ||
| $184.69M+4.0% | $177.54M+105% | $86.63M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Alto Neuroscience's total assets?
- Alto Neuroscience (ANRO) holds $276.3M in total assets, up 60.7% year over year.
- How much debt does Alto Neuroscience have?
- Alto Neuroscience carries $20.9M in total debt against $243.4M of shareholders' equity, a debt-to-equity ratio of 0.09.
- How much cash does Alto Neuroscience have?
- Alto Neuroscience holds $264.3M in cash and equivalents.
- Can Alto Neuroscience cover its short-term obligations?
- Its current ratio is 20.52 — current assets exceed current liabilities.
- Where does Alto Neuroscience's balance sheet data come from?
- Every line is extracted from Alto Neuroscience's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.